123 related articles for article (PubMed ID: 38175403)
1. Iron-laden blasts in refractory acute myeloid leukemia.
Vossen C; Im R; Horna P
J Hematop; 2023 Sep; 16(3):187-188. PubMed ID: 38175403
[TBL] [Abstract][Full Text] [Related]
2. Normal karyotype in a case of acute myeloid leukemia with monocytic differentiation and hemophagocytosis by leukemic blasts.
Salazar KL; Mosse C
Lab Med; 2015; 46(1):64-8. PubMed ID: 25617396
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis.
Ageberg M; Drott K; Olofsson T; Gullberg U; Lindmark A
Genes Chromosomes Cancer; 2008 Apr; 47(4):276-87. PubMed ID: 18181180
[TBL] [Abstract][Full Text] [Related]
5. Erythrophagocytosis by leukemic blasts in acute myeloid leukemia with a normal karyotype and no detectable mutations.
Collins NG; O'Connor HM; Lindsey KG
Proc (Bayl Univ Med Cent); 2020 Jan; 33(1):65-66. PubMed ID: 32063774
[TBL] [Abstract][Full Text] [Related]
6. Studies in acute leukemia. I. Antibody-dependent and spontaneous cellular cytotoxicity by leukemic blasts from patients with acute nonlymphoid leukemia.
Fernandes G; Garrett T; Nair M; Straus D; Good RA; Gupta S
Blood; 1979 Sep; 54(3):573-80. PubMed ID: 288485
[TBL] [Abstract][Full Text] [Related]
7.
Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
[TBL] [Abstract][Full Text] [Related]
8. Are routine iron stains on bone marrow trephine biopsy specimens necessary?
Stuart-Smith SE; Hughes DA; Bain BJ
J Clin Pathol; 2005 Mar; 58(3):269-72. PubMed ID: 15735158
[TBL] [Abstract][Full Text] [Related]
9. The measurement of ferritin in the leukemic blasts with a "sandwich" type enzyme immunoassay method.
Tanaka M; Kato K
Cancer; 1983 Jan; 51(1):61-4. PubMed ID: 6336973
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells.
Ashmun RA; Look AT; Roberts WM; Roussel MF; Seremetis S; Ohtsuka M; Sherr CJ
Blood; 1989 Feb; 73(3):827-37. PubMed ID: 2465043
[TBL] [Abstract][Full Text] [Related]
11. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
13. Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangement.
Lauw MIS; Qi Z; Eversmeyer L; Prakash S; Wen KW; Yu J; Monaghan SA; Aggarwal N; Wang L
Hum Pathol; 2022 May; 123():11-19. PubMed ID: 35167894
[TBL] [Abstract][Full Text] [Related]
14. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
15. Perls' Prussian Blue Stains of Lung Tissue, Bronchoalveolar Lavage, and Sputum.
Ghio AJ; Roggli VL
J Environ Pathol Toxicol Oncol; 2021; 40(1):1-15. PubMed ID: 33639069
[TBL] [Abstract][Full Text] [Related]
16. Unusual blasts with basophilic granules in 2 cases of de novo acute myeloid leukemia with inv3(q21q26.2) and monosomy 7 and coexpression of CD2 and CD31.
Treaba DO; Chaump M; Merriam P; Ferreira K; Souza L; Winer ES; Barker BE
Ann Diagn Pathol; 2014 Feb; 18(1):33-40. PubMed ID: 23896391
[TBL] [Abstract][Full Text] [Related]
17. Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition.
Panda D; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Sardana R; Chaturvedi A; Rajpal S; Shetty D; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 May; 100(3):331-344. PubMed ID: 32738100
[TBL] [Abstract][Full Text] [Related]
18. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
[TBL] [Abstract][Full Text] [Related]
19. Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation.
Vinante F; Rigo A; Tecchio C; Patuzzo C; Ricetti MM; Morosato L; Cassatella MA; Chilosi M; Pizzolo G
Haematologica; 1996; 81(3):195-200. PubMed ID: 8767523
[TBL] [Abstract][Full Text] [Related]
20. Hemosiderin in leukocytes of dogs with immune-mediated hemolytic anemia.
Gaunt SO; Baker DC
Vet Clin Pathol; 1986; 15(3):8-10. PubMed ID: 15221704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
